Inozyme Pharma (INZY)
NASDAQ:INZY
US Market
Holding INZY?
Track your performance easily

Inozyme Pharma (INZY) Balance Sheet

694 Followers

Inozyme Pharma Balance Sheet

Inozyme Pharma's total assets for Q3 2024 were $143.36M, a decrease of -7.93% from the previous quarter. INZY total liabilities were $60.57M for the fiscal quarter, a -1.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 200.85M$ 139.19M$ 123.54M$ 169.36M$ 47.94M
Total Liabilities
$ 60.37M$ 20.80M$ 14.27M$ 11.26M$ 81.16M
Total Equity Gross Minority
$ 140.48M$ 118.39M$ 109.27M$ 158.10M$ -33.22M
Total Capitalization
$ 230.93M$ 128.50M$ 111.91M$ 159.39M$ -33.22M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Inozyme Pharma Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis